2,272 research outputs found
Echo-Mapping of Swift J1753.5-0127
We present two epochs of coordinated X-ray-optical timing observations of the
black hole candidate Swift J1753.5-0127 during its 2005 outburst. The first
epoch in July occurred at outburst peak. Two consecutive nights of observations
using the McDonald Observatory Argos camera with the Rossi X-ray Timing
Explorer show a consistent correlation with an immediate response and an
extended tail lasting ~5s. The properties of the variability and the
correlation are consistent with thermal reprocessing in an accretion disk. The
shortness of the lag suggests a short orbital period consistent with that
recently claimed. The second epoch in August used the VLT FORS2 HIT mode again
in conjunction with RXTE. Again a repeatable correlation is seen between two
independent subsets of the data. In this case, though, the cross-correlation
function has an unusual structure comprising a dip followed by a double-peak.
We suggest that this may be equivalent to the dip plus single peak structure
seen by Kanbach et al. (2001) in XTE J1118+480 and attributed there to
synchrotron emission; a similar structure was seen during later activity of
Swift J1753.5-0127 by Durant et al. (2008).Comment: 7 pages, accepted for publication in Monthly Notices of the Royal
Astronomical Societ
Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin.
Complete replication of hepatitis C virus in cell culture.
Many aspects of the hepatitis C virus (HCV) life cycle have not been reproduced in cell culture, which has slowed research progress on this important human pathogen. Here, we describe a full-length HCV genome that replicates and produces virus particles that are infectious in cell culture (HCVcc). Replication of HCVcc was robust, producing nearly 10(5) infectious units per milliliter within 48 hours. Virus particles were filterable and neutralized with a monoclonal antibody against the viral glycoprotein E2. Viral entry was dependent on cellular expression of a putative HCV receptor, CD81. HCVcc replication was inhibited by interferon-alpha and by several HCV-specific antiviral compounds, suggesting that this in vitro system will aid in the search for improved antivirals
Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver
Background: Colorectal cancer is the third most frequently diagnosed cancer and the third cause of cancer deaths in the United States. Despite the fact that tumor cell-intrinsic mechanisms controlling colorectal carcinogenesis have been identified, novel prognostic and diagnostic tools as well as novel therapeutic strategies are still needed to monitor and target colon cancer progression. We and others have previously shown, using mouse models, that the extracellular matrix (ECM), a major component of the tumor microenvironment, is an important contributor to tumor progression. In order to identify candidate biomarkers, we sought to define ECM signatures of metastatic colorectal cancers and their metastases to the liver. Methods: We have used enrichment of extracellular matrix (ECM) from human patient samples and proteomics to define the ECM composition of primary colon carcinomas and their metastases to liver in comparison with normal colon and liver samples. Results: We show that robust signatures of ECM proteins characteristic of each tissue, normal and malignant, can be defined using relatively small samples from small numbers of patients. Comparisons with gene expression data from larger cohorts of patients confirm the association of subsets of the proteins identified by proteomic analysis with tumor progression and metastasis. Conclusions: The ECM protein signatures of metastatic primary colon carcinomas and metastases to liver defined in this study, offer promise for development of diagnostic and prognostic signatures of metastatic potential of colon tumors. The ECM proteins defined here represent candidate serological or tissue biomarkers and potential targets for imaging of occult metastases and residual or recurrent tumors and conceivably for therapies. Furthermore, the methods described here can be applied to other tumor types and can be used to investigate other questions such as the role of ECM in resistance to therapy
The Relationship Between X-ray Luminosity and Duty Cycle for Dwarf Novae and their Specific Frequency in the Inner Galaxy
We measure the duty cycles for an existing sample of well observed, nearby
dwarf novae using data from AAVSO, and present a quantitative empirical
relation between the duty cycle of dwarf novae outbursts and the X-ray
luminosity of the system in quiescence. We have found that , where
DC stands for duty cycle. We note that there is intrinsic scatter in this
relation greater than what is expected from purely statistical errors. Using
the dwarf nova X-ray luminosity functions from \citet{Pretorius12} and
\citet{Byckling10}, we compare this relation to the number of dwarf novae in
the Galactic Bulge Survey which were identified through optical outbursts
during an 8-day long monitoring campaign. We find a specific frequency of X-ray
bright () Cataclysmic Variables undergoing
Dwarf Novae outbursts in the direction of the Galactic Bulge of
. Such a specific frequency would give
a Solar neighborhood space density of long period CVs of
pc. We advocate the use of specific
frequency in future work, given that projects like LSST will detect DNe well
outside the distance range over which .Comment: 9 pagers, 4 figures Accepted for publication in MNRA
The massive neutron star or low-mass black hole in 2S0921-630
We report on optical spectroscopy of the eclipsing Halo LMXB 2S0921-630, that
reveals the absorption line radial velocity curve of the K0III secondary star
with a semi-amplitude K_2=92.89 +/- 3.84 km/s, a systemic velocity
=34.9 +/- 3.3 \kms and an orbital period P_orb of 9.0035 +/- 0.0029 day
(1-sigma). Given the quality of the data, we find no evidence for the effects
of X-ray irradiation. Using the previously determined rotational broadening of
the mass donor, and applying conservative limits on the orbital inclination, we
constrain the compact object mass to be 2.0-4.3 Msolar (1-sigma), ruling out a
canonical neutron star at the 99% level. Since the nature of the compact object
is unclear, this mass range implies that the compact object is either a
low-mass black hole with a mass slightly higher than the maximum neutron star
mass (2.9 Msolar) or a massive neutron star. If the compact object is a black
hole, it confirms the prediction of the existence of low-mass black holes,
while if the object is a massive neutron star its high mass severely constrains
the equation of state of nuclear matter.Comment: Accepted by ApJ
Constraining the nature of the accreting binary in CXOGBS J174623.5-310550
We report optical and infrared observations of the X-ray source CXOGBS
J174623.5-310550. This Galactic object was identified as a potential quiescent
low-mass X-ray binary accreting from an M-type donor on the basis of optical
spectroscopy and the broad Halpha emission line. The analysis of X-shooter
spectroscopy covering 3 consecutive nights supports an M2/3-type spectral
classification. Neither radial velocity variations nor rotational broadening is
detected in the photospheric lines. No periodic variability is found in I- and
r'-band light curves. We derive r' = 20.8, I = 19.2 and Ks = 16.6 for the
optical and infrared counterparts with the M-type star contributing 90% to the
I-band light. We estimate its distance to be 1.3-1.8 kpc. The lack of radial
velocity variations implies that the M-type star is not the donor star in the
X-ray binary. This could be an interloper or the outer body in a hierarchical
triple. We constrain the accreting binary to be a < 2.2 hr orbital period
eclipsing cataclysmic variable or a low-mass X-ray binary lying in the
foreground of the Galactic Bulge.Comment: (9 pages, 5 figures, accepted for publication in MNRAS
Deformability of Tumor Cells versus Blood Cells
The potential for circulating tumor cells (CTCs) to elucidate the process of cancer metastasis and inform clinical decision-making has made their isolation of great importance. However, CTCs are rare in the blood, and universal properties with which to identify them remain elusive. As technological advancements have made single-cell deformability measurements increasingly routine, the assessment of physical distinctions between tumor cells and blood cells may provide insight into the feasibility of deformability-based methods for identifying CTCs in patient blood. To this end, we present an initial study assessing deformability differences between tumor cells and blood cells, indicated by the length of time required for them to pass through a microfluidic constriction. Here, we demonstrate that deformability changes in tumor cells that have undergone phenotypic shifts are small compared to differences between tumor cell lines and blood cells. Additionally, in a syngeneic mouse tumor model, cells that are able to exit a tumor and enter circulation are not required to be more deformable than the cells that were first injected into the mouse. However, a limited study of metastatic prostate cancer patients provides evidence that some CTCs may be more mechanically similar to blood cells than to typical tumor cell lines.Janssen Pharmaceutical Ltd.National Cancer Institute (U.S.). Physical Sciences Oncology Center (U54CA143874)MIT-Harvard Center of Cancer Nanotechnology Excellence (Grant 26697290-47281-A)Stand Up To CancerNational Institutes of Health (U.S.). P41 Biotechnology Resource CenterNational Cancer Institute (U.S.) (Koch Institute Support Grant P30-CA14051
- …